An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cell and Developmental Biology"
DOI: 10.3389/fcell.2022.975684
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is the most aggressive digestive malignancy due to frequent late-stage diagnosis, rapid progression and resistance to therapy. With increasing PDAC incidence worldwide, there is an urgent need for new prognostic biomarkers… read more here.
Keywords: m5c score; prognosis; signature; m5c ... See more keywords
Modification of m5C regulators in sarcoma can guide different immune infiltrations as well as immunotherapy
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Surgery"
DOI: 10.3389/fsurg.2022.948371
Abstract: Background Recent studies have found that 5-methylcytosine (m5C) modulators are associated with the prognosis and treatment of cancer. However, the relevance of m5C modulators in sarcoma prognosis and the tumour microenvironment is unclear. Methods We… read more here.
Keywords: m5c score; modification; m5c regulators; m5c ... See more keywords